Get startedLog in
    Picture of Pharmicell Co logo

    005690 — Pharmicell Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Pharmicell Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARSAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line9,51310,8853,5786,33140,289
    Depreciation
    Amortisation
    Non-Cash Items-14487.51,7551,457-2,481
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-16,327-5,2433,640-7,353212
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-5,2227,91411,8143,49841,055
    Capital Expenditures-4,304-18,949-6,016-4,278-7,453
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-5,041-1,58411,932-2,522-24,876
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Sale of Intangible Assets
    Change in Net Intangibles
    Other Investing Cash Flow
    Cash from Investing Activities-9,345-20,5325,916-6,800-32,329
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities18,512-270-18,713-3,21512,477
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash5,272-11,853-635-5,46320,592